0001104659-24-065214.txt : 20240524
0001104659-24-065214.hdr.sgml : 20240524
20240524210017
ACCESSION NUMBER: 0001104659-24-065214
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240524
FILED AS OF DATE: 20240524
DATE AS OF CHANGE: 20240524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Oliviero James F III
CENTRAL INDEX KEY: 0001434718
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38128
FILM NUMBER: 24986078
MAIL ADDRESS:
STREET 1: C/O KERYX BIOPHARMACEUTICALS, INC.
STREET 2: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Checkpoint Therapeutics, Inc.
CENTRAL INDEX KEY: 0001651407
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472568632
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 95 SAWYER ROAD
STREET 2: SUITE 110
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 95 SAWYER ROAD
STREET 2: SUITE 110
CITY: WALTHAM
STATE: MA
ZIP: 02453
4
1
tm2415549-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-05-24
0
0001651407
Checkpoint Therapeutics, Inc.
CKPT
0001434718
Oliviero James F III
95 SAWYER RD, SUITE 110
WALTHAM
MA
02453
1
1
0
0
CEO, President and Director
0
COMMON STOCK (RESTRICTED)
2024-05-24
4
A
0
1660000
0.00
A
2001780
D
The shares of restricted stock vest as follows: one-third on January 31, 2025, one-third on January 31, 2026 and one-third on January 31, 2027.
Includes shares of restricted common stock, which vest over various time periods.
/s/ James F. Oliviero, III
2024-05-24